Evidence map›Paper›PMID 26695726›Full record

ArticleAngewandte Chemie (International ed. in English)2016

Nanopharmacological Force Sensing to Reveal Allosteric Coupling in Transporter Binding Sites.

Rong Zhu, Doris Sinwel, Peter S Hasenhuetl, Kusumika Saha, Vivek Kumar, Peng Zhang, Christian Rankl, Marion Holy, Sonja Sucic, Oliver Kudlacek and 8 more

Abstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. YidC fromBiomolecules · 2023
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Building membrane nanopores.Nature nanotechnology · 2017
    Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 4 institutions in 2 countries.

Rong ZhuInstitute for Biophysics, Johannes Kepler University Linz, Gruberstrasse 40, 4020, Linz, Austria.
Doris SinwelInstitute for Biophysics, Johannes Kepler University Linz, Gruberstrasse 40, 4020, Linz, Austria.
Peter S HasenhuetlCenter of Physiology and Pharmacology, Medical University of Vienna, Waehringerstrasse 13a, 1090, Vienna, Austria.
Kusumika SahaCenter of Physiology and Pharmacology, Medical University of Vienna, Waehringerstrasse 13a, 1090, Vienna, Austria.
Vivek KumarMedicinal Chemistry Section, Molecular Targets and Medications Discovery Branch, Intramural Research Program, National Institute on Drug Abuse, Baltimore, MD, 21224, USA.
Peng ZhangMedicinal Chemistry Section, Molecular Targets and Medications Discovery Branch, Intramural Research Program, National Institute on Drug Abuse, Baltimore, MD, 21224, USA.
Christian RanklKeysight Technologies Austria GmbH, Mooslackengasse 17, 1190, Vienna, Austria.
Marion HolyCenter of Physiology and Pharmacology, Medical University of Vienna, Waehringerstrasse 13a, 1090, Vienna, Austria.
Sonja SucicCenter of Physiology and Pharmacology, Medical University of Vienna, Waehringerstrasse 13a, 1090, Vienna, Austria.
Oliver KudlacekCenter of Physiology and Pharmacology, Medical University of Vienna, Waehringerstrasse 13a, 1090, Vienna, Austria.
Andreas KarnerInstitute for Biophysics, Johannes Kepler University Linz, Gruberstrasse 40, 4020, Linz, Austria.
Walter SandtnerCenter of Physiology and Pharmacology, Medical University of Vienna, Waehringerstrasse 13a, 1090, Vienna, Austria.
Thomas StocknerCenter of Physiology and Pharmacology, Medical University of Vienna, Waehringerstrasse 13a, 1090, Vienna, Austria.
Hermann J GruberInstitute for Biophysics, Johannes Kepler University Linz, Gruberstrasse 40, 4020, Linz, Austria.
Michael FreissmuthCenter of Physiology and Pharmacology, Medical University of Vienna, Waehringerstrasse 13a, 1090, Vienna, Austria.
Amy Hauck NewmanMedicinal Chemistry Section, Molecular Targets and Medications Discovery Branch, Intramural Research Program, National Institute on Drug Abuse, Baltimore, MD, 21224, USA.
Harald H SitteCenter of Physiology and Pharmacology, Medical University of Vienna, Waehringerstrasse 13a, 1090, Vienna, Austria.
Peter HinterdorferInstitute for Biophysics, Johannes Kepler University Linz, Gruberstrasse 40, 4020, Linz, Austria. peter.hinterdorfer@jku.at.
Medical University of Vienna · ATJohannes Kepler University of Linz · ATNational Institute on Drug Abuse · USKeysight Technologies (Austria) · AT

Funding

Novel Probes for the Monoamine TransportersZIADA000389 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI NEWMAN, AMY HAUCK · 2009 to 2025
$14.4M
Monoamine Transporter NanoprobesZIADA000610 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI NEWMAN, AMY HAUCK · 2016 to 2020
$2.5M
Austrian Science Fund FWF F 3503Austrian Science Fund FWF F 3506Austrian Science Fund FWF F 3510Austrian Science Fund FWF F 3524Austrian Science Fund FWF P 27518Austrian Science Fund FWF W 1232Intramural NIH HHS ZIA DA000389
6 · The paper itself

Abstract

Controversy regarding the number and function of ligand binding sites in neurotransmitter/sodium symporters arose from conflicting data in crystal structures and molecular pharmacology. Here, we have designed novel tools for atomic force microscopy that directly measure the interaction forces between the serotonin transporter (SERT) and the S- and R-enantiomers of citalopram on the single molecule level. This approach is based on force spectroscopy, which allows for the extraction of dynamic information under physiological conditions thus inaccessible via X-ray crystallography. Two distinct populations of characteristic binding strengths of citalopram to SERT were revealed in Na(+)-containing buffer. In contrast, in Li(+) -containing buffer, SERT showed only low force interactions. Conversely, the vestibular mutant SERT-G402H merely displayed the high force population. These observations provide physical evidence for the existence of two binding sites in SERT when accessed in a physiological context. Competition experiments revealed that these two sites are allosterically coupled and exert reciprocal modulation.

Indexed as

NanotechnologyAllosteric RegulationBinding SitesCrystallography, X-RaySerotonin Plasma Membrane Transport ProteinsSerotonin Plasma Membrane Transport Proteinsallosterybinding sitescitalopramnanopharmacologyserotonin transporter

Identifiers

PMID26695726
PMCPMC4932834
OpenAlexW2278829983

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.